PGA
ENTA icon

Portland Global Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Portland Global Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Hold
24,275
– – 0.03% 115
2025
Q4 		$383K Hold
24,275
– – 0.04% 108
2025
Q3 		$291K Sell
24,275
-8,910
-27% -$71.2K 0.03% 125
2025
Q2 		$251K Hold
33,185
– – 0.03% 128
2025
Q1 		$183K Hold
33,185
– – 0.02% 130
2024
Q4 		$191K Hold
33,185
– – 0.02% 134
2024
Q3 		$344K Hold
33,185
– – 0.04% 110
2024
Q2 		$430K Buy
33,185
+8,810
+36% +$119K 0.06% 100
2024
Q1 		$426K Sell
24,375
-9,800
-29% -$130K 0.06% 102
2023
Q4 		$322K Hold
34,175
– – 0.05% 102
2023
Q3 		$382K Hold
34,175
– – 0.06% 96
2023
Q2 		$731K Hold
34,175
– – 0.12% 78
2023
Q1 		$1.38M Sell
34,175
-2,030
-6% -$96.9K 0.24% 68
2022
Q4 		$1.68M Hold
36,205
– – 0.31% 63
2022
Q3 		$1.88M Sell
36,205
-11,905
-25% -$696K 0.38% 57
2022
Q2 		$2.27M Sell
48,110
-5,250
-10% -$285K 0.44% 54
2022
Q1 		$3.8M Sell
53,360
-22,509
-30% -$1.46M 0.65% 43
2021
Q4 		$5.67M Buy
75,869
+13,234
+21% +$1.04M 0.95% 31
2021
Q3 		$3.56M Buy
+62,635
New +$3.1M 0.66% 41

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Portland Global Advisors's ENTA Position: Q1 2026 in Review

Portland Global Advisors held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 24,275 shares worth $307K. The position accounts for 0.03% of the portfolio, ranked #115.

Portland Global Advisors first reported a position in ENTA in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.67M in Q4 2021. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Portland Global Advisors held 24,275 shares of Enanta Pharmaceuticals worth $307K as of Q1 2026.
  • Portland Global Advisors left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
  • Enanta Pharmaceuticals made up 0.03% of Portland Global Advisors's portfolio in Q1 2026, its #115 holding.
  • Portland Global Advisors first reported a position in Enanta Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Portland Global Advisors's Enanta Pharmaceuticals position peaked at $5.67M in Q4 2021.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.